Validation of the Korean version of the composite autonomic symptom scale-31 (COMPASS-31)
Young-Wook Kim(Daegu Gyeongbuk Institute of Science and Technology), B.J. Kim(Samsung Medical Center), Jin Myoung Seok(Samsung Medical Center), Ju‐Hong Min(Samsung (South Korea)), J. Youn(Samsung Medical Center), J.W. Cho(Samsung Medical Center)
Cited by 1
Related Papers
Comprehensive molecular characterization of mitochondrial genomes in human cancers
|Nature Genetics|2020|516
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82
Comprehensive Molecular Characterization of Mitochondrial Genomes in Human Cancers
|bioRxiv (Cold Spring Harbor Laboratory)|2017|64